Andrea Duranti

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 24

Top Venues

Pharmaceuticals (Basel, Switzerland)

Biomedicines

Antioxidants (Basel, Switzerland)

International journal of molecular sciences

University of Urbino Carlo Bo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Urbino Carlo Bo

Italy

Associate professor :: Biomolecular Sciences

Publications

Tiziana Genovese, Andrea Duranti, Francesco Monaco, Rosalba Siracusa, Roberta Fusco, Daniela Impellizzeri, Ramona D'amico, Marika Cordaro, Salvatore Cuzzocrea, Rosanna Di Paola
Inhibition of Fatty Acid Amide Hydrolase (FAAH) Regulates NF-kb Pathways Reducing Bleomycin-Induced Chronic Lung Inflammation and Pulmonary Fibrosis. International journal of molecular sciences 24 (12) (2023)
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, Giuseppe Lamanna, Maria Cristina Lumuscio, Alessandro Tossi, Jean-Pierre Majoral, Serge Mignani, Andrea Duranti, Giovanni Lentini
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective. Biomedicines 11 (2) (2023)
Agnese Gagliardi, Silvia Voci, Nicola Ambrosio, Massimo Fresta, Andrea Duranti, Donato Cosco
Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Agnese Gagliardi, Silvia Voci, Nicola Ambrosio, Massimo Fresta, Andrea Duranti, Donato Cosco
Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Federica Centofanti, Alessandro Buono, Michele Verboni, Carlo Tomino, Simone Lucarini, Andrea Duranti, Pier Paolo Pandolfi, Giuseppe Novelli
Synthetic Methodologies and Therapeutic Potential of Indole-3-Carbinol (I3C) and Its Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, Giuseppe Lamanna, Maria Cristina Lumuscio, Alessandro Tossi, Jean-Pierre Majoral, Serge Mignani, Andrea Duranti, Giovanni Lentini
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective. Biomedicines 11 (2) (2023)
Tiziana Genovese, Andrea Duranti, Francesco Monaco, Rosalba Siracusa, Roberta Fusco, Daniela Impellizzeri, Ramona D'amico, Marika Cordaro, Salvatore Cuzzocrea, Rosanna Di Paola
Inhibition of Fatty Acid Amide Hydrolase (FAAH) Regulates NF-kb Pathways Reducing Bleomycin-Induced Chronic Lung Inflammation and Pulmonary Fibrosis. International journal of molecular sciences 24 (12) (2023)
Michele Verboni, Maurizio Sisti, Raffaella Campana, Serena Benedetti, Francesco Palma, Lucia Potenza, Simone Lucarini, Andrea Duranti
Synthesis and Biological Evaluation of 6- O -Sucrose Monoester Glycolipids as Possible New Antifungal Agents. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Agnese Gagliardi, Silvia Voci, Nicola Ambrosio, Massimo Fresta, Andrea Duranti, Donato Cosco
Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Michele Verboni, Diego Romano Perinelli, Carol Yingshan Qiu, Mattia Tiboni, Annalisa Aluigi, Simone Lucarini, Jenny K W Lam, Andrea Duranti
Synthesis and Properties of Sucrose- and Lactose-Based Aromatic Ester Surfactants as Potential Drugs Permeability Enhancers. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, Giuseppe Lamanna, Maria Cristina Lumuscio, Alessandro Tossi, Jean-Pierre Majoral, Serge Mignani, Andrea Duranti, Giovanni Lentini
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective. Biomedicines 11 (2) (2023)
Michele Verboni, Diego Romano Perinelli, Alessandro Buono, Raffaella Campana, Maurizio Sisti, Andrea Duranti, Simone Lucarini
Sugar-Based Monoester Surfactants: Synthetic Methodologies, Properties, and Biological Activities. Antibiotics (Basel, Switzerland) 12 (10) (2023)
Marco Agostini, Donata Favretto, Caterina Renzoni, Susanna Vogliardi, Andrea Duranti
Characterization of URB Series Synthetic Cannabinoids by HRMS and UHPLC-MS/MS. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Tiziana Genovese, Andrea Duranti, Francesco Monaco, Rosalba Siracusa, Roberta Fusco, Daniela Impellizzeri, Ramona D'amico, Marika Cordaro, Salvatore Cuzzocrea, Rosanna Di Paola
Inhibition of Fatty Acid Amide Hydrolase (FAAH) Regulates NF-kb Pathways Reducing Bleomycin-Induced Chronic Lung Inflammation and Pulmonary Fibrosis. International journal of molecular sciences 24 (12) (2023)
Aitor Benedicto, Beatriz Arteta, Andrea Duranti, Daniel Alonso-Alconada
The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Agnese Gagliardi, Roberto Molinaro, Massimo Fresta, Andrea Duranti, Donato Cosco
α-Acylamino-β-lactone N -Acylethanolamine-hydrolyzing Acid Amidase Inhibitors Encapsulated in PLGA Nanoparticles: Improvement of the Physical Stability and Protection of Human Cells from Hydrogen Peroxide-Induced Oxidative Stress. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Michele Verboni, Serena Benedetti, Raffaella Campana, Francesco Palma, Lucia Potenza, Maurizio Sisti, Andrea Duranti, Simone Lucarini
Synthesis and Biological Characterization of the New Glycolipid Lactose Undecylenate (URB1418). Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Tiziana Genovese, Andrea Duranti, Ramona D'amico, Roberta Fusco, Daniela Impellizzeri, Alessio Filippo Peritore, Rosalia Crupi, Enrico Gugliandolo, Salvatore Cuzzocrea, Rosanna Di Paola, Rosalba Siracusa, Marika Cordaro
Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury. International journal of molecular sciences 23 (5) (2022)
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, Matilde Sbriscia, Silvia Carloni, Walter Balduini, Daniel Alonso-Alconada
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic-Ischemic Brain Injury. Biomedicines 11 (1) (2022)
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, Matilde Sbriscia, Silvia Carloni, Walter Balduini, Daniel Alonso-Alconada
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic-Ischemic Brain Injury. Biomedicines 11 (1) (2022)
Michele Verboni, Simone Lucarini, Andrea Duranti
6'- O -Lactose Ester Surfactants as an Innovative Opportunity in the Pharmaceutical Field: From Synthetic Methods to Biological Applications. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Simone Lucarini, Maria Gessica Ciulla, Paola Mestichelli, Andrea Duranti
Total Synthesis of Natural Disaccharide Sambubiose. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Raffaella Campana, Alessio Merli, Michele Verboni, Francesca Biondo, Gianfranco Favi, Andrea Duranti, Simone Lucarini
Synthesis and Evaluation of Saccharide-Based Aliphatic and Aromatic Esters as Antimicrobial and Antibiofilm Agents. Pharmaceuticals (Basel, Switzerland) 12 (4) (2019)
Simone Lucarini, Laura Fagioli, Robert Cavanagh, Wanling Liang, Diego Romano Perinelli, Mario Campana, Snjezana Stolnik, Jenny K W Lam, Luca Casettari, Andrea Duranti
Synthesis, Structure⁻Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers. Pharmaceutics 10 (3) (2018)

Andrea Duranti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrea Duranti